Catherine Fievet

Catherine Fievet publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Catherine Fievet sits on this spectrum.

Catherine Fievet D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Catherine Fievet sits on this spectrum.

Overview

Best Publications

• Protective role of interleukin-10 in atherosclerosis

  Ziad Mallat;Sandrine Besnard;Micheline Duriez;Virginie Deleuze

  1253
  Citations

• Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice

  Nicholas M. Morton;Janice M. Paterson;Hiroaki Masuzaki;Megan C. Holmes

  625
  Citations

• Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.

  Liam R. Brunham;Janine K. Kruit;Jahangir Iqbal;Catherine Fievet

  624
  Citations

• Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice *

  Nicholas M. Morton;Megan C. Holmes;Catherine Fiévet;Bart Staels

  608
  Citations

• Metabolic syndrome without obesity: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice

  Janice M. Paterson;Nicholas M. Morton;Catherine Fievet;Christopher J. Kenyon

  554
  Citations

• Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient Mice

  Jeffrey M. Peters;Nathalie Hennuyer;Bart Staels;Jean Charles Fruchart

  547
  Citations

• Activation of PPARδ alters lipid metabolism in db/db mice

  Mark D. Leibowitz;Catherine Fiévet;Nathalie Hennuyer;Julia Peinado-Onsurbe

  432
  Citations

• Increased ABCA1 activity protects against atherosclerosis

  Roshni R. Singaraja;Catherine Fievet;Graciela Castro;Erick R. James

  359
  Citations

• Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor

  Thierry Claudel;Mark D. Leibowitz;Catherine Fiévet;Anne Tailleux

  350
  Citations

• Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

  Nicolas Duverger;Howard Kruth;Florence Emmanuel;Jean-Michel Caillaud

  319
  Citations

• Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.

  Roshni R. Singaraja;Virginie Bocher;Erick R. James;Susanne M. Clee

  271
  Citations

• Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription

  Eric Raspé;Hélène Duez;Anethe Mansén;Coralie Fontaine

  263
  Citations

• Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine.

  Caroline Duval;Véronique Touche;Véronique Touche;Véronique Touche;Anne Tailleux;Anne Tailleux;Anne Tailleux;Jean-Charles Fruchart;Jean-Charles Fruchart;Jean-Charles Fruchart

  259
  Citations

• Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice

  Hélène Duez;Yu-Sheng Chao;Melba Hernandez;Gérard Torpier

  248
  Citations

• PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome

  Catherine Fiévet;Jean-Charles Fruchart;Jean-Charles Fruchart;Jean-Charles Fruchart;Bart Staels;Bart Staels;Bart Staels

  247
  Citations

• Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

  Anne-Marie Lefebvre;Julia Peinado-Onsurbe;Iris Leitersdorf;Michael R. Briggs

  195
  Citations

• 17β-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice

  R. Elhage;J.-F. Arnal;M.-T. Pieraggi;N. Duverger

  187
  Citations

• Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.

  G Luc;C Fievet;D Arveiler;A E Evans

  175
  Citations

• Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor α Modulation

  Hélène Duez;Bruno Lefebvre;Philippe Poulain;Inés Pineda Torra

  168
  Citations

• Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha.

  Eric Raspé;Hélène Duez;Phillippe Gervois;Catherine Fiévet

  167
  Citations